Abstract Recombinant adeno-associated virus (rAAV) vectors mediate long-term gene transfer without any known toxicity. The primary limitation of rAAV has been the small size of the virion (20 nm), which only permits the packaging of 4.7 kilobases (kb) of exogenous DNA, including the promoter, the polyadenylation signal and any other enhancer elements that might be desired. Two recent reports (D Duan et al: Nat Med 2000, 6:595-598; Z Yan et al: Proc Natl Acad Sci USA 2000, 97:6716-6721) have exploited a unique feature of rAAV genomes, their ability to link together in doublets or strings, to bypass this size limitation. This technology could improve the chances for successful gene therapy of diseases like cystic fibrosis or Duchenne muscular...
Gene delivery vehicles, or vectors, based on adeno-associated viruses (AAV) have demonstrated succes...
International audienceIn recent years, the field of in vivo gene transfer with adeno-associated viru...
Recently, efficient and long-term in vivo gene transfer by recombinant adeno-associated virus type 2...
AbstractBecause of its ability to integrate chromosomally and its non-pathogenic nature, adeno-assoc...
The application of recombinant Adeno-Associated Virus (rAAV) vectors as gene delivery vehicles has b...
The use of adeno-associated viral (AAV) vectors for gene therapy treatments of inherited disorders h...
Adeno-associated virus is an integrating DNA parvovirus with the potential to be an important vehicl...
Gene therapy with adeno-associated viral (AAV) vectors has reached the clinical stage for many inher...
Human gene therapy has advanced from twentieth-century conception to twenty-first-century reality. T...
Recombinant adeno-associated virus (rAAV) holds promise for applications in gene therapy. Advances i...
The limited packaging capacity of adeno-associated virus (AAV) precludes the design of vectors for t...
Recent advances in recombinant adeno-associated virus vector production. Adeno-associated virus (AAV...
Clinical gene therapy has been increasingly successful owing both to an enhanced molecular understan...
Vectors derived from adeno-associated virus (AAV) are promising for human gene therapy, including tr...
Adeno-associated virus (AAV) shows great promise for gene therapy, however scalability, yield and qu...
Gene delivery vehicles, or vectors, based on adeno-associated viruses (AAV) have demonstrated succes...
International audienceIn recent years, the field of in vivo gene transfer with adeno-associated viru...
Recently, efficient and long-term in vivo gene transfer by recombinant adeno-associated virus type 2...
AbstractBecause of its ability to integrate chromosomally and its non-pathogenic nature, adeno-assoc...
The application of recombinant Adeno-Associated Virus (rAAV) vectors as gene delivery vehicles has b...
The use of adeno-associated viral (AAV) vectors for gene therapy treatments of inherited disorders h...
Adeno-associated virus is an integrating DNA parvovirus with the potential to be an important vehicl...
Gene therapy with adeno-associated viral (AAV) vectors has reached the clinical stage for many inher...
Human gene therapy has advanced from twentieth-century conception to twenty-first-century reality. T...
Recombinant adeno-associated virus (rAAV) holds promise for applications in gene therapy. Advances i...
The limited packaging capacity of adeno-associated virus (AAV) precludes the design of vectors for t...
Recent advances in recombinant adeno-associated virus vector production. Adeno-associated virus (AAV...
Clinical gene therapy has been increasingly successful owing both to an enhanced molecular understan...
Vectors derived from adeno-associated virus (AAV) are promising for human gene therapy, including tr...
Adeno-associated virus (AAV) shows great promise for gene therapy, however scalability, yield and qu...
Gene delivery vehicles, or vectors, based on adeno-associated viruses (AAV) have demonstrated succes...
International audienceIn recent years, the field of in vivo gene transfer with adeno-associated viru...
Recently, efficient and long-term in vivo gene transfer by recombinant adeno-associated virus type 2...